Japan Celiac Disease Treatment Market Size, Share, and COVID-19 Impact Analysis, By Treatment (Vitamins & Minerals, Gluten Degrading Enzymes, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Others), and Japan Celiac Disease Treatment Market Insights, Industry Trend, Forecasts to 2035

Japan Celiac Disease Treatment Market Insights Forecasts to 2035

• The Japan Celiac Disease Treatment Market Size Was Estimated at USD 34.8 million in 2024
• The Market Size is Expected to Grow at a CAGR of Around 12.71 % from 2025 to 2035
• The Japan Celiac Disease Treatment Market Size is Expected to Reach USD 129.8 million by 2035

According to a Research Report Published by Spherical Insights & Consulting, The Japan Celiac Disease Treatment Market Size is anticipated to Reach USD 129.8 Million by 2035, Growing at a CAGR of 12.71 % from 2025 to 2035. The celiac disease treatment market in Japan is driven by various factors, including rising prevalence of diagnosed celiac disease cases, rising awareness about the disease, government initiatives, and advancements in diagnostic technology

Market Overview

The Japan Celiac Disease Treatment Market Size focuses on diagnosis, management, and treatment of celiac disease. Celiac disease is a chronic autoimmune condition that develops in people who are genetically predisposed to it after consuming gluten, a protein present in wheat, barley, and rye. The primary component of celiac disease treatment is a lifelong gluten-free diet, which is frequently bolstered by vitamin and mineral supplements to address nutritional deficiencies. In certain situations, the use of gluten-degrading enzymes is being investigated to help break down trace amounts of gluten and lessen the effects of unintentional exposure. The diagnosis and awareness of celiac disease have significantly increased in Japan, which has raised demand for efficient treatment alternatives. The Japanese government has taken steps to enhance diagnostic procedures and health education because it recognizes the importance of addressing this health issue. As a result, more medical personnel are receiving training on how to recognize celiac disease, which is essential for prompt treatment. The rising demand for gluten-free products is a key trend in this market. Ongoing research into potential vaccines or enzyme-based therapies to mitigate gluten reactions offers promising opportunities for future growth.

Report Coverage

This research report categorizes the market for the Japan celiac disease treatment market based on various segments and regions, and forecasts revenue growth and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the Japan celiac disease treatment market. Recent market developments and competitive strategies, such as expansion, product launch, development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the japan celiac disease treatment market.

Driving Factors

The people are becoming more educated about celiac diseases and medical training, which has led to higher recognition and diagnostic rates of celiac diseases, which boosts the market for effective treatments. Technological developments are booming in the Japanese celiac disease treatment market, especially in the creation of gluten-free products and medical therapies, which has led to the expansion of the market. Additionally, the rising availability of gluten-free products led to a positive impact on the market growth.

Restraining Factors

The lack of knowledge among the public and medical experts can lead to long-term consequences, excessive discomfort, and delayed diagnosis, which limit the market expansion. Additionally, limited treatment options further hinder the market growth.

Market Segmentation

The Japan celiac disease treatment market share is classified into treatment and distribution channel.   

• The vitamins & minerals segment held the dominant share of the market in 2024 and is expected to grow at a rapid CAGR during the forecast period.   

The Japan celiac disease treatment market is segmented by treatment into vitamins & minerals, gluten degrading enzymes, and others.  Among these, the vitamins & minerals held the dominant share in 2024 and are expected to grow at a rapid CAGR during the forecast period. This is due to individuals with celiac disease experiencing nutrient deficiencies. Supplementation with targeted vitamins and minerals helps address these deficiencies and enhance overall health.

• The retail pharmacies segment held the largest share in 2024 and is expected to grow at a significant CAGR during the forecast period.  

The Japan celiac disease treatment market is segmented by distribution channel into hospital pharmacies, retail pharmacies, and others. Among these, the retail pharmacies segment held the largest share in 2024 and is expected to grow at a significant CAGR during the forecast period. This is due to the easy accessibility of medications, vitamins, and over-the-counter products.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the Japan celiac disease treatment market, along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• Daiichi Sankyo
• Hokkaido System Science
• Kaken Pharmaceutical
• Ono Pharmaceutical
• Eisai
• Mitsubishi Tanabe Pharma
• Astellas Pharma
• Takeda Pharmaceutical
• Santen Pharmaceutical
• Mitsubishi Chemical Holdings
• Others

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Market Segment

This study forecasts revenue at the Japan, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the Japan celiac disease treatment market based on the below-mentioned segments:

Japan Celiac Disease Treatment Market, By Treatment

• Vitamins & Minerals
• Gluten Degrading Enzymes
• Others

Japan Celiac Disease Treatment Market, By Distribution Channel

• Hospital Pharmacies
• Retail Pharmacies
• Others